Clinical trialCLINICALTRIALSMay 12
Trial Now Recruiting: Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases (NCT06285539)
Researchers are testing a new drug approach for three rare immune diseases: Behçet's disease, inflammatory myopathy (muscle inflammation), and IgG4-related disease. Currently, patients with these conditions take strong steroids and other immunosuppressive medications for long periods, which can cause serious side effects like infections. This trial is looking for a safer alternative treatment option.
WHY IT MATTERSIf you have Behçet's disease, idiopathic inflammatory myopathy, or IgG4-related disease and are struggling with side effects from long-term steroid use, this Phase 2 trial is actively recruiting 60 patients and may offer access to a potentially safer treatment option.